ETON PHARMACEUTICALS

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

04 окт 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

23 авг 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

10 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

01 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 июн 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 май 2023 16:01:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 май 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 мар 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 янв 2023 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 окт 2022 06:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 сен 2022 09:00:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 авг 2022 08:00:02 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 июл 2022 07:05:00 Источник Nasdaq GlobeNewswire